From Groundbreaking Science to the Clinic From Groundbreaking Science to the Clinic From Groundbreaking Science to the Clinic

about receptos

We are a Phase 3 clinical stage biopharmaceutical company focused on discovering, developing and commercializing innovative therapeutics in immune disease. Our lead asset, RPC1063, is being developed as an oral therapy for Relapsing Multiple Sclerosis (RMS) and Inflammatory Bowel Disease (IBD). The goal of our development strategy for RPC1063 is to demonstrate clinically meaningful differentiation versus other available treatments, including a favorable safety profile.
Meet the team »

news


Fatal error: Uncaught exception 'Exception' with message 'String could not be parsed as XML' in /data/8/1/41/137/1530952/user/1647874/htdocs/index.php:121 Stack trace: #0 /data/8/1/41/137/1530952/user/1647874/htdocs/index.php(121): SimpleXMLElement->__construct('') #1 {main} thrown in /data/8/1/41/137/1530952/user/1647874/htdocs/index.php on line 121